← Open Payments lookup

RANDI SILLER: Open Payments

NPI 1881918258 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$537 in 13 payments from 9 companies in 2025. Trend: 2023 $240 · 2024 $520 · 2025 $537

Food & beverage: $537
CompanyPaymentsAmount
Astellas Pharma US Inc2$169
Janssen Biotech, Inc.3$96
PFIZER INC.2$64
JAZZ PHARMACEUTICALS INC.1$60
Merck Sharp & Dohme LLC1$34
GlaxoSmithKline, LLC.1$32
Incyte Corporation1$29
SOBI, INC1$29
Gamida Cell Inc.1$24

Products named: Xospata, DARZALEX, ELREXFIO, DEFITELIO, PREVYMIS, OJJAARA, Cresemba, NIKTIMVO.

Industry payments across TX — which companies pay providers there.